The term “LLS” is used for patients with dMMR tumors (specifically CRC and EC) with no MLH1, MSH2, MSH6, PMS2, or EPCAM deletion variants or MLH1 somatic methylation. This evidence concerns the gene EPCAM and colorectal carcinoma.